Carmen Burtea
Avenue Victor Maistriau 19, Mendeleyev Building
Mons, WAL 7000, Belgium
Mons, WAL 7000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Toward the development of an innovative pharmacological compound employing peptides for EGFR-mediated drug delivery in anaplastic thyroid carcinoma.
Journal: Biochemical pharmacology
Published: June 10, 2025
Editorial for: "Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging".
Journal: Journal of magnetic resonance imaging : JMRI
Published: November 04, 2023
Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer's Disease.
Journal: Journal of Alzheimer's disease reports
Published: July 20, 2023
New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications.
Journal: International journal of molecular sciences
Published: December 05, 2022
Molecular and cellular biology of PCSK9: impact on glucose homeostasis.
Journal: Journal of drug targeting
Published: June 20, 2022
Editorial for "New Cluster Analysis Method for Quantitative DCE-MRI Assessing Tumor Heterogeneity Induced by E7130 Treatment to a Breast Cancer Mouse Model".
Journal: Journal of magnetic resonance imaging : JMRI
Published: March 23, 2022
Novel Polymeric Micelles-Coated Magnetic Nanoparticles for In Vivo Bioimaging of Liver: Toxicological Profile and Contrast Enhancement.
Journal: Materials (Basel, Switzerland)
Published: May 25, 2020
Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes.
Journal: Biology
Published: January 20, 2020
Modulation of adiponectin receptors AdipoR1 and AdipoR2 by phage display-derived peptides in in vitro and in vivo models.
Journal: Journal of drug targeting
Published: January 01, 2020
Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa.
Journal: Molecules (Basel, Switzerland)
Published: August 01, 2018
Last Updated: 09/26/2026